Create Account
B
Johnson & Johnson
JNJ
NYSE
$157.83 -$1.92-1.20% Volume5,705,639 11/30/2021 1:48PM Eastern Quotes delayed
Recommendation
Buy
Prev Close
$159.75
Avg Vol (90D)
6,270,513
Market Cap
$420.56B
Dividend & Yield
$4.19(2.62%)
52-Week Range
$143.06 - $179.92
P/E (TTM)
23.88
EPS (TTM)
$6.69
My Lists
My Alerts
Rating
Reward
A-
Excellent
Risk
C+
Fair
Rating Factors
Growth Index
Excellent
Efficiency Index
Excellent
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
Good
Headlines
Johnson & Johnson (NYSE:JNJ) Shares Sold by Raymond James Trust N.A.
11/30/2021 - Ticker Report
RMR Wealth Builders Sells 332 Shares of Johnson & Johnson (NYSE:JNJ)
11/30/2021 - Ticker Report
M. Kraus & Co Boosts Position in Johnson & Johnson (NYSE:JNJ)
11/30/2021 - Zolmax
COVID-19 experts answer questions about Omicron - and where the variant may have come from
11/30/2021 - GeekWire
4 Top Dividend Dogs Of The Aristocrats Tagged To Buy For December
11/30/2021 - SeekingAlpha
FDA working with other agencies, private industry on potential impact from Omicron
11/30/2021 - SeekingAlpha.com: All News
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
11/30/2021 - Fool.com Headlines
J&J (JNJ) to Explore Omicron Version of its COVID Vaccine
11/30/2021 - Zacks Investment Research
What Does Johnson & Johnson's Debt Look Like?
11/30/2021 - Benzinga
Aspen closes in on Africa license for Johnson & Johnson's COVID-19 vaccine
11/30/2021 - FiercePharma.com
2022 Franklin Institute Awards Announced: Covid Vaccine CEOs Honored For Business Leadership
11/30/2021 - Forbes.com: Healthcare News
EU expects to approve shot against Omicron in 3-4 months
11/30/2021 - SeekingAlpha.com: All News
England to impose mask mandates to curb spread Omicron - Reuters
11/30/2021 - SeekingAlpha.com: All News
Pfizer already working on Covid vaccine targeting Omicron: CEO
11/30/2021 - IB Times - Top News
Wall Street rebounds after virus-related sell-off
11/29/2021 - The Malay Mail Money
Johnson & Johnson (NYSE:JNJ) Shares Bought by Islay Capital Management LLC
11/29/2021 - Ticker Report
Amid Omicron, CDC now says everyone 18 and older should get COVID booster shot
11/29/2021 - Seeking Alpha - Healthcare
Gradient Investments LLC Increases Stock Position in Johnson & Johnson (NYSE:JNJ)
11/29/2021 - Zolmax
Biden to direct regulators to use 'fastest process available" to clear vaccines against Omicron
11/29/2021 - SeekingAlpha.com: All News
Intersect Capital LLC Sells 2,684 Shares of Johnson & Johnson (NYSE:JNJ)
11/29/2021 - Zolmax
Biden urges COVID-19 shots, says omicron in U.S. inevitable
11/29/2021 - The Mercury News: Health
5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market
11/29/2021 - InvestorPlace
Walter & Keenan Financial Consulting Co. MI ADV Has $7.82 Million Position in Johnson & Johnson (NYSE:JNJ)
11/29/2021 - Zolmax
J&J researching Omicron-specific COVID vaccine
11/29/2021 - SeekingAlpha.com: All News
Gracell Bio Shares Tumble as Investors Blow Hot, Cold Over Its Cutting-Edge Cancer Treatment
11/29/2021 - Benzinga
Income Statement
Total Revenue (TTM)
$91.45B
EBITDA (TTM)
$31.53B
EBIT (TTM)
$24.04B
Net Income (TTM)
$17.88B
Balance Sheet
Total Assets (Q)
$179.23B
Total Debt (Q)
$33.93B
Total Liabilities (Q)
$108.96B
Book Value Per Share (Q)
$26.69
Cash Flow
Cash from Operations (TTM)
$26.02B
Cash from Investing (TTM)
-$11.23B
Cash from Financing (TTM)
-$16.26B
Net Change in Cash (TTM)
-$1.36B
Filings
Filing Date
Friday, October 29, 2021
Period Date
Thursday, September 30, 2021
Next Filing
Week of Feb 21 and 25 (est)
Price History
Loading...
Beta
0.60
7-Day Total Return
-2.18%
30-Day Total Return
-0.79%
60-Day Total Return
-9.25%
90-Day Total Return
-6.98%
Year to Date Total Return
3.39%
1-Year Total Return
11.83%
2-Year Total Return
20.99%
3-Year Total Return
16.32%
5-Year Total Return
61.79%
52-week Low
Nov 30, 2020 - $143.06
52-week High
Aug 20, 2021 - $179.92
Valuation
Market Cap
$420.56B - Mega Cap
Enterprise Value
$420.91B
Price/Sales (TTM)
4.67
Price/Book (Q)
5.98
Dividends and Shares
Shares Outstanding
2.67B
Dividend Per Share (Most Recent)
$1.06
Dividend Per Share (TTM)
$4.19
Corporate Info
Website
www.jnj.com
Phone Number
732 524 0400
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
Country
United States
Year Founded
1886
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and... more
Weiss Ratings